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This paper presents a brief update on ultrasound bioeffects. Benefits and risks of
ultrasound examinations and the concept of ALARA, i.e., exposure As Low As
Reasonably Achievable, are introduced. Output display standards (Thermal [TI] and
Mechanical [MI] Indices) provide information on the potential for bioeffects and
help to implement ALARA easily and efficiently. Some key aspects of guidelines
and regulations from major ultrasound organizations that offer valuable information
helping users apply diagnostic ultrasound in a safe and effective manner are highlighted.
Although future harmful bioeffects may be identified, current data indicate that the
benefits to the patient outweigh the small risks. Awareness of risk and the safe
practice of ultrasound investigations are important. Continuing education is needed
to ensure that appropriate risk/benefit assessments are made based on current
knowledge, paving the way for self-regulation.
(J Med Ultrasound 2002;10:5–9)
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ULTRASOUND BIOPHYSICS AND BIOEFFECTS
There has been very extensive research aimed at
understanding basic mechanisms and evaluating the
potential for tissue injury by ultrasound (US). When
US propagates through human tissue, there are
potential biologic effects. Many studies are dose-
effect studies, and virtually all US-induced adverse
bioeffects have occurred at higher intensities than
diagnostic US.
There are two mechanisms for measuring US
bioeffects: thermal (measured as the thermal index,
TI) and non-thermal (measured as the mechanical
index, MI). As a sound beam passes through tissue,
it undergoes attenuation. A significant fraction of
this attenuation is due to absorption. For low power
US, the heat deposited is quickly dissipated. Some
concern is warranted with pulsed Doppler and color
flow imaging equipment, where high power levels
and time average intensities may give large TI values.
The principal non-thermal (mechanical) interac-
tions deal with the generation, growth, vibration and
possible collapse of microbubbles within tissue. This
behavior is known as cavitation. Two types of
cavitation exist: stable cavitation refers to the crea-
tion of bubbles that oscillate with sound beams;
transient cavitation refers to the process in which
the oscillation grows so strong that the bubbles
collapse violently, producing very intense, localized
effects. The MI aims to provide information for the
operator on the potential for cavitation. The terms
TI and MI are fully defined later in this paper.
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There are excellent review articles and books on
the biologic effects and safety of diagnostic ultra-
sound [1–8].
IS THERE A RISK?
The question of safety has received much interna-
tional attention because technically sophisticated
equipment with higher output is being used clinically.
Just because we have not detected bioeffects on
humans at diagnostic US levels does not mean that
they do not exist. We know that the potential for
risks exists. It is important for practitioners to know
about biophysics and bioeffects so that they can
make informed decisions to safeguard patients.
There are three sources of information on US
bioeffects to help us determine the risk factors:
epidemiology, in vitro cell studies and animal studies.
Epidemiology
No adverse effects, including no evidence of low
birth weights from diagnostic US, have been
demonstrated. The American Institute of Ultrasound
in Medicine (AIUM) evaluated epidemiologic stud-
ies and concluded that: “Widespread clinical use
over 25 years has not established any adverse effect
arising from exposure to diagnostic ultrasound” [2].
Randomized clinical studies are the most rigorous
method for assessing potential adverse effects of
diagnostic US. Studies using this methodology show
no evidence of any effect on birth weight in humans.
Other epidemiologic studies have shown no causal
association of diagnostic US with any of the adverse
fetal outcome studies.
In vitro cell studies
In vitro studies generally expose macromolecules,
membrane transport systems, cells, or clumps of
cells suspended in liquid to diagnostic US. AIUM
stated that: “Although the exposure conditions and
mechanisms are different from in vivo situations, an
in vitro effect must be regarded as a real effect of
US”
Animal studies
Most animal studies were done at spatial peak-
temporal average (SPTA) intensities and exposure
times that exceeded diagnostic values. At high time-
average intensity levels, fetal weight reduction in
rats, death of rat fetuses and altered mitotic rates
were observed. For these effects to be produced,
animals were exposed to some minimal time-aver-
age intensity for a given period. If the intensity was
reduced, the exposure time had to be increased to
compensate for the reduced acoustic energy.
The Figure shows the intensity (I) versus time
(T) curve relevant to the production of bioeffects
in mammalian tissue [2, 9]. The line (below 100
mW/cm2) divides the data into a region of positive
biologic effects and a no-effect-observed region. The
line follows a curve for intensity, greater than 100
mW/cm2 in which I x T = 50 J/cm2. AIUM claims
that no bioeffects were observed for intensities as
high as 1 W/cm2 for highly focused beams (dotted
line in the Figure).
DEVELOPMENT OF REGULATION AND
SAFETY GUIDELINES
Unlike ionizing radiation, there are few international
safety standards for the clinical use of US or standards
for the calibration of output from diagnostic
equipment. The FDA introduced application-specific
limits on acoustic output for the USA only. The
permissible limit was lowest for ophthalmic (17 mW/
cm2 SPTA intensity, ISPTA) and fetal (94 mW/cm
2 ISPTA
Figure. Intensity (spatial peak-temporal average) versus
time curve relevant to the production of bioeffects in
mammalian tissue. (Reproduced with permission from
Essentials of Ultrasound Physics, St. Louis, Mosby, 1996).
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exposures, where the tissues are particularly sensi-
tive to damage.
There is a large body of scientific literature on
bioeffects, but it is difficult to interpret much of the
early work in the context of the safety of diagnostic
US because the exposure conditions used were not
clinically relevant. It was often difficult to find
biologic endpoints that were sufficiently sensitive to
respond because modest acoustic outputs were used.
The Bioeffects Committee of AIUM has stated that
there is no evidence of independently confirmed
adverse significant biologic effects in mammalian
tissue exposed in vivo to intensities (ISPTA) below
100 mW/cm2 [2]. The situation became more com-
plicated when it was first reported that bleeding
could be induced in lung capillaries in mice fol-
lowing exposure to diagnostic levels of US at average
intensities far below 100 mW/cm2 [4]. This finding
has subsequently been verified in other animal species
[5].
A significant development in safety was the in-
troduction of the output display standard providing
real-time acoustical output labeling developed in
1992 [10, 11]. Two quantities related to acoustical
output levels are defined: TI and MI. The TI estimates
the potential for producing thermally induced
bioeffects in soft tissue and bones (soft tissue TI
[TIS], cranial bone TI [TIC], bone TI [TIB]). The
MI estimates the potential for producing non-thermal/
mechanical bioeffects in tissue. TI is the ratio of
acoustical power produced by the transducer to the
power required to raise the temperature of the tissue
by 1°C. A TI value of 1 means that, under tissue
conditions assumed in the algorithm, a 1°C elevation
of temperature is possible. The MI value is com-
puted from the peak rarefactional pressure and the
frequency, and is intended to estimate the potential
for mechanical bioeffects. The higher the index
value, the higher the probability for bioeffects
occurring; values of less than 1 are generally con-
sidered ‘safe’. Due to the difficulties of estimating
tissue conditions, these indices provide indicators of
risks rather than quantifiable values. They do not
take into account factors such as dwell time, ex-
amination time, patient temperature or presence of
contrast agents.
BENEFITS AND RISKS — THE ALARA
The extensive clinical application of US over many
decades has proven, beyond doubt, its diagnostic
benefit. Nonetheless, we must bear in mind the
potential risks of US. Another risk that must also
be considered is that of not doing the US exami-
nation at all, or choosing a less desirable or more
invasive way. Moreover, attention must now be fo-
cused on evaluating the cost of morbidity resulting
from suboptimal equipment that gave poor diagnos-
tic results.
How do we balance benefits and risks? Prudent
use can be achieved by applying the simple concept
of ALARA, i.e., As Low As Reasonably Achievable.
Following ALARA principles means that we keep
total US exposure as low as reasonably achievable,
while optimizing diagnostic information.
There are operator controls for improving image
quality and minimizing output intensity. First are
those controls that directly affect output intensity.
Then, there are controls that change the character-
istics of the transmitted US field and indirectly affect
intensity: system mode, pulse repetition frequency,
focusing depth, pulse length and transducer choice.
The ‘receiver controls’ help to improve image quality
and include receiver gain, time gain compensation
(TGC), video dynamic range and postprocessing.
There is also the philosophical aspect of ALARA.
This includes minimizing scan time, justifying the
clinical examination, and not compromising image
quality by rushing through an examination.
Because the threshold of bioeffect intensity is not
known, it is the responsibility of the operator to use
his/her judgment and insight to adjust the intensity
output of the equipment, so as to get the most
information at the lowest output power.
It is appropriate to quote here the complete AIUM
statement on clinical safety [3].
“Diagnostic ultrasound has been in use since the
late 1950’s. Given its known benefits and recognized
efficacy for medical diagnosis, including use during
human pregnancy, the American Institute of Ultra-
sound in Medicine herein addresses the clinical
safety of such use:
No confirmed biological effects on patients or
instrument operators caused by exposure at intensities
typical of present diagnostic ultrasound instruments
have ever been reported. Although the possibility
exists that such biological effects may be identified
in the future, current data indicate that the benefits
to patients of the prudent use of diagnostic ultrasound
outweigh the risks, if any, that may be present.”
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INTERNATIONAL STANDARDS AND
GUIDELINES
The key aspects of guidelines and regulations from
organizations such as the World Federation for Ultra-
sound in Medicine and Biology (WFUMB), AIUM,
European Federation of Societies for Ultrasound in
Medicine and Biology (EFSUMB) and the US Food
and Drug Administration (FDA) are highlighted in
the Table. These recommendations and guidelines
offer valuable information to help users apply di-
agnostic US in a safe and effective manner [12].
Table. Published recommendations by major ultrasound (US) organizations on the safe use of diagnostic US
WFUMB = World Federation for Ultrasound in Medicine and Biology; AIUM = American Institute of Ultrasound in Medicine;
EFSUMB = European Federation of Societies for Ultrasound in Medicine and Biology; ODS/FDA = Output Display Standard/
US Food and Drug Administration; ISPTA = spatial peak-temporal average intensity; MI = mechanical index; TI = thermal index.
Modified from reference 12.
B-mode
Doppler
Exposure
 levels
Thermal
 effects
Non-thermal
 effects
First
 trimester
 exposure
Epidemiology
WFUMB
Not contraindicated on
thermal grounds
when no gas is present
Use lowest available
power for obtaining
good diagnostic
information. Minimize
time beam passes
through one point
Temperature rises of
≤ 1.5°C (to 38°C)
can be used without
reservation. Obstetric
exposures resulting in
temperature increases
of 4°C for 5 min are
potentially hazardous
When gas (includes
contrast agents) is
present, exposure levels
and duration should be
reduced to the minimum
required to obtain  diag-
nostic information
EFSUMB
Prudent use involves
minimum output
levels and exposure
times
Absence of knowl-
edge about 1st
trimester US expo-
sures means that care
is required in the
application of trans-
vaginal US in early
pregnancy
AIUM
Refer to ODS (output
display standard)
At the FDA, regula-
tory limit (ISPTA 0.3 =
720 mW/cm2) maxi-
mum temperature
increase in the
conceptus can exceed
2°C
The threshold value
of MI for extravasation
of blood cells in
mouse lung is
approximately 0.3
There is insufficient
evidence of a causal
relationship between
diagnostic US and
adverse effects
ODS/FDA
FDA upper intensity
limit: ophthalmic
exposures, < 50
mW/cm2; others:
< 720 mW/cm2
FDA does not regulate
TI; for general use,
TI should be < 6
For general use,
MI should be < 1.9
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International guidelines and recommendations are
needed to address the following areas of concern:
• Use of Doppler US in the first trimester;
• Epidemiology, especially of obstetric examinations;
• Non-clinical use of US imaging;
• New applications and techniques such as har-
monic imaging using contrast agents.
There is a trend towards self-regulation, resulting
in a move away from FDA-enforced, application-
specific limits on acoustic output to a system where
bioeffects are assessed from the real-time display of
safety indices. This shift of responsibility of risk
assessment from a regulatory authority to the users
creates an urgent need for continuing education and
the awareness of safety issues. The international US
community must be ready for this change.
CONCLUSION
Currently used US scanners have higher acoustic
power, which is potentially hazardous in certain
applications, such as obstetrics and neonatology. As
the clinical applications of US increase rapidly in
Asia, we should create safety awareness and em-
phasize the safety aspects of diagnostic US. There
is a strong need for continuing education to ensure
that appropriate risk/benefit assessments are made
by practitioners based on current knowledge, thus,
paving the way for self-regulation. It is timely that
the Asian Federation of Societies for Ultrasound in
Medicine and Biology (AFSUMB) formulate guide-
lines for the safe use of US and endorse the guide-
lines and recommendations of the WFUMB.
Furthermore, the AFSUMB should participate ac-
tively in US bioeffect and safety research.
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